Bristol Myers Squibb Co. Stock Falls Tuesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slipped 0.28% to $72.31 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.20% to 3,990.97 and Dow Jones Industrial Average falling 1.14% to 33,910.85. Bristol Myers Squibb Co. closed $9.13 short of its 52-week high ($81.44), which the company reached on December 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.62% to $172.36, Pfizer Inc. (PFE) fell 3.70% to $46.08, and Abbott Laboratories (ABT) fell 0.11% to $113.39. Trading volume (8.9 M) remained 128,201 below its 50-day average volume of 9.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 17, 2023.
(END) Dow Jones Newswires
January 17, 2023 16:42 ET (21:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.